MDA SPACE LTD (MDA.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:MDA - CA55293N1096 - Common Stock
27 CAD
0 (0%)
We assign a fundamental rating of 6 out of 10 to MDA. MDA was compared to 11 industry peers in the Aerospace & Defense industry. While MDA has a great profitability rating, there are some minor concerns on its financial health. MDA is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings could make MDA a good candidate for growth investing.
1. Profitability
1.1 Basic Checks
MDA had positive earnings in the past year.
In the past year MDA had a positive cash flow from operations.
Of the past 5 years MDA 4 years were profitable.
MDA had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of MDA (3.15%) is better than 83.33% of its industry peers.
The Return On Equity of MDA (8.24%) is better than 91.67% of its industry peers.
MDA has a Return On Invested Capital of 5.12%. This is comparable to the rest of the industry: MDA outperforms 50.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MDA is below the industry average of 8.45%.
The last Return On Invested Capital (5.12%) for MDA is above the 3 year average (3.99%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.15% | ||
| ROE | 8.24% | ||
| ROIC | 5.12% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
1.3 Margins
MDA has a Profit Margin of 7.40%. This is amongst the best in the industry. MDA outperforms 91.67% of its industry peers.
In the last couple of years the Profit Margin of MDA has grown nicely.
The Operating Margin of MDA (9.86%) is comparable to the rest of the industry.
MDA's Operating Margin has improved in the last couple of years.
MDA has a better Gross Margin (24.62%) than 75.00% of its industry peers.
In the last couple of years the Gross Margin of MDA has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.86% | ||
| PM (TTM) | 7.4% | ||
| GM | 24.62% |
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MDA is destroying value.
Compared to 1 year ago, MDA has more shares outstanding
The debt/assets ratio for MDA has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.39, we must say that MDA is in the distress zone and has some risk of bankruptcy.
MDA has a better Altman-Z score (1.39) than 83.33% of its industry peers.
MDA has a debt to FCF ratio of 0.92. This is a very positive value and a sign of high solvency as it would only need 0.92 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.92, MDA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
A Debt/Equity ratio of 0.31 indicates that MDA is not too dependend on debt financing.
MDA has a Debt to Equity ratio of 0.31. This is amongst the best in the industry. MDA outperforms 83.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 0.92 | ||
| Altman-Z | 1.39 |
ROIC/WACC0.58
WACC8.79%
2.3 Liquidity
MDA has a Current Ratio of 0.55. This is a bad value and indicates that MDA is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.55, MDA is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
MDA has a Quick Ratio of 0.55. This is a bad value and indicates that MDA is not financially healthy enough and could expect problems in meeting its short term obligations.
MDA has a Quick ratio of 0.54. This is in the better half of the industry: MDA outperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.55 | ||
| Quick Ratio | 0.54 |
3. Growth
3.1 Past
MDA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 98.25%, which is quite impressive.
Measured over the past years, MDA shows a very strong growth in Earnings Per Share. The EPS has been growing by 185.75% on average per year.
The Revenue has grown by 57.77% in the past year. This is a very strong growth!
MDA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 31.32% yearly.
EPS 1Y (TTM)98.25%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%-16.67%
Revenue 1Y (TTM)57.77%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%45.11%
3.2 Future
MDA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.78% yearly.
MDA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.84% yearly.
EPS Next Y105.61%
EPS Next 2Y49.06%
EPS Next 3Y35.78%
EPS Next 5YN/A
Revenue Next Year52.26%
Revenue Next 2Y30.25%
Revenue Next 3Y23.84%
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 23.89, MDA is valued on the expensive side.
MDA's Price/Earnings ratio is a bit cheaper when compared to the industry. MDA is cheaper than 75.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.92, MDA is valued at the same level.
The Price/Forward Earnings ratio is 17.36, which indicates a rather expensive current valuation of MDA.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MDA is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.46, MDA is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.89 | ||
| Fwd PE | 17.36 |
4.2 Price Multiples
MDA's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. MDA is cheaper than 66.67% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, MDA is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.31 | ||
| EV/EBITDA | 13.77 |
4.3 Compensation for Growth
MDA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of MDA may justify a higher PE ratio.
MDA's earnings are expected to grow with 35.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.23
PEG (5Y)N/A
EPS Next 2Y49.06%
EPS Next 3Y35.78%
5. Dividend
5.1 Amount
No dividends for MDA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TSX:MDA (12/24/2025, 7:00:00 PM)
27
0 (0%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners38.36%
Inst Owner ChangeN/A
Ins Owners1.17%
Ins Owner ChangeN/A
Market Cap3.41B
Revenue(TTM)1.48B
Net Income(TTM)109.60M
Analysts78.33
Price Target40.74 (50.89%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.07%
Min EPS beat(2)-40.3%
Max EPS beat(2)22.16%
EPS beat(4)3
Avg EPS beat(4)5.53%
Min EPS beat(4)-40.3%
Max EPS beat(4)22.16%
EPS beat(8)6
Avg EPS beat(8)21.97%
EPS beat(12)10
Avg EPS beat(12)31.49%
EPS beat(16)13
Avg EPS beat(16)66.41%
Revenue beat(2)1
Avg Revenue beat(2)0.06%
Min Revenue beat(2)-0.24%
Max Revenue beat(2)0.35%
Revenue beat(4)3
Avg Revenue beat(4)3.66%
Min Revenue beat(4)-0.24%
Max Revenue beat(4)7.65%
Revenue beat(8)5
Avg Revenue beat(8)2.65%
Revenue beat(12)9
Avg Revenue beat(12)2.56%
Revenue beat(16)11
Avg Revenue beat(16)1.78%
PT rev (1m)-0.91%
PT rev (3m)-6.33%
EPS NQ rev (1m)-3.09%
EPS NQ rev (3m)-3.95%
EPS NY rev (1m)-1.04%
EPS NY rev (3m)-2.26%
Revenue NQ rev (1m)0.11%
Revenue NQ rev (3m)-0.77%
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)-0.06%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.89 | ||
| Fwd PE | 17.36 | ||
| P/S | 2.3 | ||
| P/FCF | 7.31 | ||
| P/OCF | 4.64 | ||
| P/B | 2.57 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.77 |
EPS(TTM)1.13
EY4.19%
EPS(NY)1.56
Fwd EY5.76%
FCF(TTM)3.69
FCFY13.67%
OCF(TTM)5.82
OCFY21.57%
SpS11.72
BVpS10.52
TBVpS-2.82
PEG (NY)0.23
PEG (5Y)N/A
Graham Number16.36
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.15% | ||
| ROE | 8.24% | ||
| ROCE | 7.1% | ||
| ROIC | 5.12% | ||
| ROICexc | 5.66% | ||
| ROICexgc | 60.4% | ||
| OM | 9.86% | ||
| PM (TTM) | 7.4% | ||
| GM | 24.62% | ||
| FCFM | 31.5% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
ROICexc(3y)4.25%
ROICexc(5y)N/A
ROICexgc(3y)14.8%
ROICexgc(5y)N/A
ROCE(3y)5.54%
ROCE(5y)N/A
ROICexgc growth 3Y59.28%
ROICexgc growth 5YN/A
ROICexc growth 3Y71.38%
ROICexc growth 5YN/A
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
F-Score6
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 0.92 | ||
| Debt/EBITDA | 1.55 | ||
| Cap/Depr | 226.87% | ||
| Cap/Sales | 18.19% | ||
| Interest Coverage | 9.36 | ||
| Cash Conversion | 277.94% | ||
| Profit Quality | 425.55% | ||
| Current Ratio | 0.55 | ||
| Quick Ratio | 0.54 | ||
| Altman-Z | 1.39 |
F-Score6
WACC8.79%
ROIC/WACC0.58
Cap/Depr(3y)234.8%
Cap/Depr(5y)169.15%
Cap/Sales(3y)23.53%
Cap/Sales(5y)18.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.25%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%-16.67%
EPS Next Y105.61%
EPS Next 2Y49.06%
EPS Next 3Y35.78%
EPS Next 5YN/A
Revenue 1Y (TTM)57.77%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%45.11%
Revenue Next Year52.26%
Revenue Next 2Y30.25%
Revenue Next 3Y23.84%
Revenue Next 5YN/A
EBIT growth 1Y64.41%
EBIT growth 3Y76.57%
EBIT growth 5YN/A
EBIT Next Year182.32%
EBIT Next 3Y52.1%
EBIT Next 5YN/A
FCF growth 1Y631.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y674.42%
OCF growth 3Y124.48%
OCF growth 5YN/A
MDA SPACE LTD / MDA.CA FAQ
What is the fundamental rating for MDA stock?
ChartMill assigns a fundamental rating of 6 / 10 to MDA.CA.
What is the valuation status for MDA stock?
ChartMill assigns a valuation rating of 6 / 10 to MDA SPACE LTD (MDA.CA). This can be considered as Fairly Valued.
What is the profitability of MDA stock?
MDA SPACE LTD (MDA.CA) has a profitability rating of 7 / 10.
What is the valuation of MDA SPACE LTD based on its PE and PB ratios?
The Price/Earnings (PE) ratio for MDA SPACE LTD (MDA.CA) is 23.89 and the Price/Book (PB) ratio is 2.57.